Clik here to view.
Overland Pharmaceuticals Appoints Roger Luo, Ph.D. as Chief Development Officer
SHANGHAI & BOSTON Overland Pharmaceuticals (“Overland”), a premier biopharmaceutical company bringing innovative medicines to patients in Asia and worldwide, today announced the appointment of...
View ArticleClik here to view.
CANbridge Pharmaceuticals CAN103 Investigational New Drug Application...
BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals Inc., a leading China-based global rare disease-focused biopharmaceutical company committed to the research, development and...
View ArticleClik here to view.
Pillar Biosciences Appoints Dr. Eric Lai to its Board of Directors
NATICK, Mass. & SHANGHAI Pillar Biosciences, an innovative next-generation sequencing (NGS) solutions in-vitro diagnostics (IVD) company, today announced the appointment of Eric Lai, Ph.D. to...
View ArticleClik here to view.
IASO Biotherapeutics’ World’s First Fully Human CD19/CD22 Dual-Targeted CAR-T...
PLEASANTON, Calif. & NANJING, China & SHANGHAI IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company advancing the development of novel cell therapies for cancer, today...
View ArticleClik here to view.
Advanced Clinical’s Graham Belgrave Named to the 2021 PharmaVOICE 100 List of...
DEERFIELD, Ill. Graham Belgrave, Senior Vice President of European Operations at Advanced Clinical, has been recognized by PharmaVOICE magazine as a distinguished leader on the 2021 PharmaVOICE 100...
View ArticleClik here to view.
武田交出稳健的2021财年第一季度业绩，促使公司加速营收增长并延续其在研产品线发展态势
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited,...
View ArticleClik here to view.
Personalis, Inc.新发表的数据显示，新型复合生物标志物NEOPS™可用于预测晚期黑色素瘤患者对癌症免疫治疗药物的应答
加州门罗帕克 (美国商业资讯)–先进转化基因组学和癌症诊断试剂领域的领导者Personalis, Inc. (Nasdaq: PSNL)今天宣布，其研究“通过新抗原负荷和免疫相关耐药机制的联合建模预测黑色素瘤对免疫治疗药物的应答”(1)已发布在美国癌症研究学会出版的《临床癌症研究》(Clinical Cancer Research)期刊中。 该研究详细介绍了Personalis...
View ArticleClik here to view.
Seagen and RemeGen Announce Exclusive Worldwide License and Co-Development...
BOTHELL, Wash. & YANTAI, China Seagen Inc. (Nasdaq: SGEN), a world leader and pioneer in antibody-drug conjugate (ADC) therapies, and RemeGen Co., Ltd. (9995.HK), a leading innovative...
View ArticleClik here to view.
Clik here to view.
Noxopharm Pre-clinical Study Confirms Survival Advantage of Combination...
SYDNEY Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) has reported pre-clinical data confirming a survival benefit of adding Veyonda® to 177lutetium-PSMA-617 (LuPSMA)...
View ArticleClik here to view.
Wastewater Testing Labs Can Detect SARS-CoV-2 in Less Than Four Hours with...
MADISON, Wis. A complete workflow developed by Promega Corporation enables wastewater testing laboratories, including public health organizations, to quickly assess the health of entire communities...
View ArticleClik here to view.
パーキンエルマーが即使用可能な新規AlphaLISAキットによりオンコロジー創薬向けKRASアッセイ製品を拡大
米マサチューセッツ州ウォルサム （ビジネスワイヤ） — より健康な世界を実現するための革新に傾倒する世界的リーダー企業のパーキンエルマーは本日、4種類の即使用可能な新規AlphaLISA®...
View ArticleClik here to view.
Incyte and InnoCare Announce Collaboration and License Agreement for...
WILMINGTON, Del. & BEIJING Incyte (NASDAQ:INCY) and InnoCare (HKEX: 09969) today announced that Incyte and a subsidiary of InnoCare have entered into a collaboration and license agreement for...
View ArticleClik here to view.
BeiGene and EUSA Pharma Announce China NMPA Approval of QARZIBA® (Dinutuximab...
CAMBRIDGE, Mass. & BEIJING & HEMEL HEMPSTEAD, England BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160) and EUSA Pharma (UK), Ltd. today announced that the China National Medical Products...
View ArticleClik here to view.
BeiGene and EUSA Pharma Announce China NMPA Approval of QARZIBA® (Dinutuximab...
CAMBRIDGE, Mass. & BEIJING & HEMEL HEMPSTEAD, England BeiGene, Ltd. (NASDAQ:BGNE; HKEX:06160) and EUSA Pharma (UK), Ltd. today announced that the China National Medical Products...
View ArticleClik here to view.
Ranok Therapeutics Secures $40 Million Series B Financing to Advance its...
BOSTON & HANGZHOU, China Ranok Therapeutics (Hangzhou) Co. Ltd., an emerging biopharmaceutical company focused on developing breakthrough therapies for cancer and other serious diseases, today...
View ArticleClik here to view.
IASO Biotherapeutics Publishes Preclinical Results of Its CD5-Targeting CAR-T...
PLEASANTON, Calif. & NANJING, China & SHANGHAI IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company advancing the development of novel cell therapies for cancer, today...
View ArticleClik here to view.
Guided Therapeutics Receives Notification of Successful Clinical Trial...
PEACHTREE CORNERS, Ga. Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva® Advanced Cervical Scan, based on its patented biophotonic technology, announced today it had passed the...
View ArticleClik here to view.
BeiGene Announces Acceptance of a Supplemental Biologics License Application...
CAMBRIDGE, Mass. & BEIJING BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced...
View ArticleClik here to view.
Applications of Bioluminescent Research Tools Showcased at Global Seminar Series
MADISON, Wis. Life science and drug discovery researchers interested in bioluminescent tools will have the opportunity to hear from global thought leaders on the possibilities and applications of...
View Article